AZ and MSD get orphan designation for neurofibromatosis drug
admin 3rd August 2018 Uncategorised 0Selumetinib is a MEK 1/2 inhibitor for the rare disease
More: AZ and MSD get orphan designation for neurofibromatosis drug
Source: News
Selumetinib is a MEK 1/2 inhibitor for the rare disease
More: AZ and MSD get orphan designation for neurofibromatosis drug
Source: News
© 1994 - 2023 B.M. Pharmaceuticals